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Background: We aimed to investigate the effect of CSWT on the expression of VEGF/VEGF and its receptors in cultured Human umbilical veins 
endothelial cells (HUVECs).
methods:  The HUVECs were prepared under 4 levels of shock wave energy (0:conchol group, 1: 0.035, 2:0.10, 3: 0.155 mJ/mm2) in vitro. 
The relationship between effect of CSWT on HUVECs proliferation and VEGF/VEGFR was explored by inhibited VEGF, Flt-1 and Flk-1 using 
ZM323881(2uM), anti-human VEGF (10ul/ml), anti-human Flt-1(10ul/ml) respectively.
results:  Cells in phase S increased were observed in all groups received CSWT compared to control group (Figure). The relative expression of VEGF 
mRNA (1.0±0.0 vs. 1.7±0.3 vs. 6.1±0.5 vs. 3.4±0.2 in group 0-3 respectively, P<0.01) and the level of VEGF (pg/ml) (396.6±42.3 vs. 410.8±55.4 vs. 
529.2±44.8 vs. 493.3±51.3 in group 0-3 respectively, P<0.05) increased in almost all CSWT groups as well as Flk-1 compared to the control group. 
The proportions of the Ki -67 expressing cells were lower among HUVECs after CSWT while VEGF, Flt-1 or Flk-1 were inhibited compared to those 
receiving CSWT without any inhibitors.
conclusion:  CSWT promote cell proliferation by enhancing gene and protein expression of VEGF and Flk-1. VEGF and its receptor might be one of 
the mechanisms of angiogenesis in CSWT. 
Figure: A: Level of Flk-1; B: Relative expression of Flk-1 mRNA; C: Percentage of cells in phase S; D: Inhibition test, percentage of cells expressing 
Ki-67 with different inhibitors after CSWT.
